Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Clinuvel Pharmaceuticals Ltd.

Clinuvel Pharmaceuticals Ltd. (CUVL) Stock Overview

Explore Clinuvel Pharmaceuticals Ltd.’s financial performance, market position, analyst ratings, and future outlook.

CUVL●NASDAQ
HealthcareMedical - Pharmaceuticals
$6.74
$0.07(0.97%)
U.S. Market opens in 11h 45m

Clinuvel Pharmaceuticals Ltd. (CUVL)

Meyka AI Score

Z

Key Financials

Market Cap339.9M
P/E RatioN/A
EPS (TTM)N/A
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$6.65
3 Months$52.34
1 Year TargetN/A

CUVL Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Clinuvel Pharmaceuticals Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CUVL on the NASDAQ shows an RSI of 43.53, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.

Key metrics behind Clinuvel Pharmaceuticals Ltd.'s NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 339.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CUVL on the NASDAQ.

Price Performance (NASDAQ: CUVL)

1-Day Change
0.97%
5-Day Change
5.15%
1-Month Change
-6.91%
3-Month Change
-4.40%
6-Month Change
-4.40%
Year-to-Date (YTD) Change
-4.40%
1-Year Change
-4.40%
3-Year Change
-4.40%
5-Year Change
-4.40%
All-Time (Max) Change
-4.40%

Contact Information

https://www.clinuvel.com
NaN
535 Bourke Street, Melbourne, VIC, 3000

Company Facts

IPO DateJul 13, 2026
CountryAU
Actively Trading

Frequently Asked Questions